NCT02444039

Brief Summary

The objective of the study is to compare the ease of use and performance of the SL-D301 with the DC-4 with other existing slit lamps imaging systems (SL-3G) from Topcon.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Nov 2014

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2014

Completed
19 days until next milestone

First Submitted

Initial submission to the registry

November 20, 2014

Completed
11 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2014

Completed
5 months until next milestone

First Posted

Study publicly available on registry

May 14, 2015

Completed
Last Updated

June 8, 2022

Status Verified

June 1, 2022

Enrollment Period

1 month

First QC Date

November 20, 2014

Last Update Submit

June 6, 2022

Conditions

Any Willing and Able Person for Ocular Imaging

Outcome Measures

Primary Outcomes (1)

  • Instrument and Device Evaluation

    1 Hour

Study Arms (1)

Any Willing and Able Person for Ocular Imaging

Any Willing and Able Person for Ocular Imaging

Device: SL-D301Device: DC-4Device: SL-3G

Interventions

SL-D301DEVICE

Slit Lamp

Any Willing and Able Person for Ocular Imaging
DC-4DEVICE

Digital Camera Attachment

Any Willing and Able Person for Ocular Imaging
SL-3GDEVICE

Slit Lamp

Any Willing and Able Person for Ocular Imaging

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Any Willing and able subjects will be recruited from Topcon Medical Systems.

You may qualify if:

  • Any willing subject

You may not qualify if:

  • Subjects unwilling to participate

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Topcon Medical Systems, Inc.

Oakland, New Jersey, 07436, United States

Location

Study Officials

  • Danny Leung

    Topcon Corporation

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 20, 2014

First Posted

May 14, 2015

Study Start

November 1, 2014

Primary Completion

December 1, 2014

Study Completion

December 1, 2014

Last Updated

June 8, 2022

Record last verified: 2022-06

Locations

US(1)